RSS   Newsletter   Contact   Advertise with us
Post Online Media

Jaguar Animal Health appoints chief scientific officer

Jaguar Animal HealthJaguar Animal Health, an animal medicine company, announced that it has appointed Roger Waltzman as chief scientific officer.
Dr. Waltzman is a human medical oncologist and experienced drug-development executive.

He spent over 10 years in academic clinical oncology practice at Memorial Sloan-Kettering, Mount Sinai, and Saint Vincent hospitals in New York, and nine years in drug development with Novartis Pharmaceuticals, leading successful NDA and sNDA filings for Glivec, Tasigna, and Jakavi, and serving most recently as Head of Development for anti-malarials at Novartis.

Dr. Waltzman earned his MD degree from Brown University School of Medicine and completed internal medicine training at Beth Israel Hospital in Boston, as well as a fellowship in hematology/oncology at Memorial Sloan-Kettering Cancer Center in New York City. He is board certified in medical oncology.




POST Online Media does not use cookies to collect information about visitors.   OK, hide this message   Third party ads may be using cookies, you can see how here.